According to a recent product liability lawsuit, defendants Johnson & Johnson and Janssen Pharmaceuticals knew that Risperidone was defective and likely to cause male breast growth in patients, but still engaged in illegal marketing practices to promote the drug. The antipsychotic medication, which is sold... Read More

A Minnesota man recently filed a lawsuit in Minnesota District Court against the makers of the powerful antipsychotic drug Risperdal. The defendants, which include Johnson & Johnson and its wholly-owned subsidiary Ortho-McNeill-Jannsen, are alleged to have unlawfully withheld information about the known risks of gynecomastia (i.e.,... Read More

A Louisiana man has filed a Risperdal lawsuit over male breast growth (gynecomastia). The plaintiff filed the complaint against Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development LLC, in the United States District Court for the Western District of Louisiana (Shreveport Division). Hundreds... Read More

A mother has filed a Risperdal gynecomastia lawsuit on behalf of her minor son, claiming use of the drug during his childhood resulted in abnormal breast growth. This complaint joins hundreds of others filed in state and federal courts involving serious and sometime permanent side... Read More

A few of the Risperdal gynecomastia lawsuits filed with regard to  are set to go to trial soon in a Pennsylvania state court. Recently, the start date of the first bellwether trial was delayed until November 3, 2014. The second trial is expected to begin... Read More

Middle-aged men who take Risperdal are 69 percent more likely to develop larger breasts (gynecomastia) than men who are not taking antipsychotic drugs, according to a new Risperdal and gynecomastia study published in the Journal of Clinical Psychopharmacology on August 6, 2014. "There has been... Read More

Faced with 500 pending Risperdal lawsuits, attorneys for Johnson & Johnson are saying many of the cases should be thrown out because the plaintiffs waited too long to file them. The lawyers for Janssen Pharmaceuticals, a subsidiary of J&J, have filed a motion for a... Read More

A new study from the University of Maryland found that off-label Risperdal use in youth may be linked more closely to socioeconomic status than sound medical practice. Researchers discovered an unusually high proportion of children in foster care taking Risperdal to treat ADHD. Findings raise... Read More